DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma-Reference-Cited by-同舟云学术

DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma

Published:2022-11 Issue: Volume:548 Page:215899
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhang Lian,Li Hong-Tao,Shereda Rachel,Lu Qianjin,Weisenberger Daniel J.,O'Connell Casey,Machida Keigo,An Woojin,Lenz Heinz-Josef,El-Khoueiry Anthony,Jones Peter A.,Liu Minmin,Liang Gangning

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference72 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca - Cancer J. Clin.,2021

2. Cancer statistics, 2014;Siegel;Ca - Cancer J. Clin.,2014

3. Exploration of liver cancer genomes;Shibata;Nat. Rev. Gastroenterol. Hepatol.,2014

4. Hepatocellular carcinoma;Llovet;Lancet,2003

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma;World Journal of Clinical Cases;2024-08-26

2. Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma;Cancer Letters;2024-07

3. Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal;Chemical Engineering Journal;2024-07

4. Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4;Clinical Epigenetics;2024-06-18

5. THAP3 recruits SMYD3 to OXPHOS genes and epigenetically promotes mitochondrial respiration in hepatocellular carcinoma;FEBS Letters;2024-04-25